drugset / Trial / NCT04126343

A Study to Test the Cardiac Effects of Padsevonil in Healthy Study Participants

NCT04126343

Phase 1 Terminated 54 enrolled UCB Biopharma S.P.R.L.
RandomizedCrossoverQuadruple-blindBasic science

Summary

The purpose of the study is to evaluate the effects on cardiac repolarization of high-dose padsevonil (PSL) in comparison to placebo in healthy study participants.

Timeline

Start
2019-10-23
Primary completion
2020-05-22
Completion
2020-05-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moxifloxacin Small molecule Oral
Subject Padsevonil Small molecule Oral

Indications

No indication recorded.